enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Pfizer beats Q4, FY '24 earnings estimates, stock flat in ...

   www.aol.com/finance/pfizer-beats-q4-fy-24...

   Pfizer reported fourth quarter and full-year 2024 earnings results Tuesday, narrowly beating Wall Street expectations and sending the stock up about 1% in premarket trading.Pfizer reported $63.6 ...

3. Pfizer raises full-year guidance by $1.5 billion amid ... - AOL

   www.aol.com/finance/pfizer-raises-full-guidance...

   Pfizer posted strong earnings in the third quarter as investors worry about the stock's value. ... Anjalee Khemlani is the senior health reporter at Yahoo Finance, covering all things pharma ...

4. Is Pfizer the Best Dividend Stock for You? - AOL

   www.aol.com/finance/pfizer-best-dividend-stock...

   PFE Revenue (TTM) data by YCharts Pfizer's vaccine (Comirnaty) and treatment option (Paxlovid) combined for $56 billion in revenue in 2022. Those two products represented just $2.4 billion of ...

5. Is Pfizer Stock Undervalued at Current Prices? - AOL

   www.aol.com/finance/pfizer-stock-undervalued...

   Pfizer (NYSE: PFE) stock investors are curious about the valuation and prospects for the healthcare company. Stock prices used were the afternoon prices of Jan. 1, 2025. The video was published on ...

6. Pfizer stock gains 7% after earnings beat, company calls ...

   www.aol.com/finance/pfizer-stock-gains-7...

   Pfizer beat on earnings in the first quarter of 2024, giving its stock a much-needed 7% boost Wednesday.The company reported $14.9 billion in revenue, down 19% compared to last year. That beat ...

7. Is Pfizer Stock in Trouble? - AOL

   www.aol.com/finance/pfizer-stock-trouble...

   One stock that just can't seem to catch a break of late is Pfizer (NYSE: PFE). Given how well Pfizer has performed in recent years due to its COVID-19 vaccine and pill (its revenue topped $100 ...

8. Pfizer: Why its FY2024 downgrade has Wall Street wary - AOL

   www.aol.com/finance/pfizer-why-fy2024-downgrade...

   Pfizer disappointed Wall Street this week with lower revenue guidance for the upcoming year, giving analysts another reason to doubt the company and its stock. Shares for Pfizer were at the end of ...

9. Pfizer CEO: The activist investors are 'too late'

   www.aol.com/finance/pfizer-ceo-activist...

   Bourla said that given the efforts made in the past year to help boost Pfizer's stock, ... Anjalee Khemlani is the senior health reporter at Yahoo Finance, covering all things pharma, insurance ...